Tuberculosis or Nontuberculosis ? a Case of Mycobacterial Skin Infection
| dc.contributor.author | Vahabi, Merve Mert | |
| dc.contributor.author | Bostanci, Aylin | |
| dc.contributor.author | Tasbakan, Selin Ece | |
| dc.contributor.author | Karaarslan, Isil | |
| dc.contributor.author | Cavusoglu, Cengiz | |
| dc.contributor.author | Tasbakan, Meltem | |
| dc.date.accessioned | 2025-01-25T17:04:26Z | |
| dc.date.available | 2025-01-25T17:04:26Z | |
| dc.date.issued | 2024 | |
| dc.description | Mert, Merve/0000-0002-5008-0139 | en_US |
| dc.description.abstract | Bacteria other than Mycobacterium tuberculosis and Mycobacterium leprae are known as nontuberculous mycobacteria (NTM), and the frequency of clinically symptomatic forms is increasing day by day. Mycobacterium fortuitum, a rapidly reproducing NTM, causes various clinical signs such as skin soft-tissue infection, surgical site infection, and disseminated infection in immunosuppressed patients. Although progress can be made in terms of diagnosis when growth is detected in culture, it is quite difficult to distinguish between infection and contamination. There is no place for antituberculosis treatment in the treatment of M. fortuitum. Antibiotics such as quinolones, trimethoprim-sulfamethoxazole, linezolid, doxycycline, clarithromycin, azithromycin, imipenem, tigecycline, linezolid, and amikacin are recommended at least in dual combination therapy. In this case presentation, the diagnosis and treatment of a 2-year skin soft-tissue infection with M. fortuitum growth in culture will be discussed. | en_US |
| dc.identifier.doi | 10.4103/ijmy.ijmy_211_23 | |
| dc.identifier.issn | 2212-5531 | |
| dc.identifier.issn | 2212-554X | |
| dc.identifier.uri | https://doi.org/10.4103/ijmy.ijmy_211_23 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/5797 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wolters Kluwer Medknow Publications | en_US |
| dc.relation.ispartof | The International Journal of Mycobacteriology | |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Mycobacterium Fortuitum | en_US |
| dc.subject | Mycobacterium Tuberculosis | en_US |
| dc.subject | Nontuberculous Mycobacteria | en_US |
| dc.title | Tuberculosis or Nontuberculosis ? a Case of Mycobacterial Skin Infection | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Mert, Merve/0000-0002-5008-0139 | |
| gdc.author.wosid | Çavuşoğlu, Cengiz/Jxx-6990-2024 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | [Vahabi, Merve Mert; Tasbakan, Meltem] Ege Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkiye; [Bostanci, Aylin; Karaarslan, Isil] Ege Univ, Fac Med, Dept Dermatol, Izmir, Turkiye; [Tasbakan, Selin Ece] Izmir Ekonomi Univ, Fac Med, Dept Microbiol, Izmir, Turkiye; [Cavusoglu, Cengiz] Ege Univ, Fac Med, Dept Microbiol, Izmir, Turkiye | en_US |
| gdc.description.endpage | 353 | en_US |
| gdc.description.issue | 3 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q3 | |
| gdc.description.startpage | 351 | en_US |
| gdc.description.volume | 13 | en_US |
| gdc.description.woscitationindex | Emerging Sources Citation Index | |
| gdc.description.wosquality | Q4 | |
| gdc.identifier.openalex | W4402550602 | |
| gdc.identifier.pmid | 39277899 | |
| gdc.identifier.wos | WOS:001376575700011 | |
| gdc.index.type | WoS | |
| gdc.index.type | PubMed | |
| gdc.oaire.accesstype | GOLD | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 4.0 | |
| gdc.oaire.influence | 2.7507754E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.keywords | nontuberculous mycobacteria | |
| gdc.oaire.keywords | Male | |
| gdc.oaire.keywords | Mycobacterium fortuitum | |
| gdc.oaire.keywords | Mycobacterium Infections, Nontuberculous | |
| gdc.oaire.keywords | Skin Diseases, Bacterial | |
| gdc.oaire.keywords | Microbiology | |
| gdc.oaire.keywords | QR1-502 | |
| gdc.oaire.keywords | Anti-Bacterial Agents | |
| gdc.oaire.keywords | Diagnosis, Differential | |
| gdc.oaire.keywords | mycobacterium fortuitum | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Tuberculosis | |
| gdc.oaire.keywords | Tuberculosis, Cutaneous | |
| gdc.oaire.keywords | mycobacterium tuberculosis | |
| gdc.oaire.popularity | 5.413258E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 1.6377 | |
| gdc.openalex.normalizedpercentile | 0.85 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.crossrefcites | 1 | |
| gdc.plumx.mendeley | 3 | |
| gdc.plumx.newscount | 1 | |
| gdc.plumx.scopuscites | 3 | |
| gdc.wos.citedcount | 2 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 |
